Analyst Expects Abbvie Inc (NYSE: ABBV) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NYSE listed company, ABBV falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Abbvie Inc is $296.75B. A total of 4.22 million shares were traded on the day, compared to an average of 5.55M shares.

In the most recent transaction, Donoghoe Nicholas sold 21,082 shares of ABBV for 176.30 per share on Mar 20 ’24. After the transaction, the EVP, CHIEF BUS/STRAT OFFICER now owns 55,903 company shares. In a previous transaction on Mar 18 ’24, Stewart Jeffrey Ryan sold 58,949 shares at 178.79 per share. ABBV shares that EVP, CHIEF COMMERCIAL OFFICER owns now total 60,941.

Among the insiders who sold shares, RICHMOND TIMOTHY J. disposed of 75,680 shares on Mar 01 ’24 at a per-share price of $177.27. This resulted in the EVP, CHIEF HR OFFICER holding 13,837 shares of ABBV after the transaction. In another insider transaction, Michael Robert A. sold 68,879 shares at $176.45 per share on Feb 29 ’24. Company shares held by the PRES & CHIEF OPERATING OFFICER now total 98,645.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Abbvie Inc pays an annual dividend of $6.06, resulting in a dividend yield of 3.61%, and it has a price to earnings (P/E) ratio of 50.04. ABBV’s most recent ex-dividend date was 7/15/2024 when it declared a $1.55 quarterly dividend that was paid in cash on 8/15/2024. Previously, the company paid the dividend on 5/15/2024 with an ex-dividend date of 4/12/2024. The ABBV stock dividend was $1.55 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ABBV has a high of $182.89 and a low of $132.70.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was $4.53, while its Total Shareholder’s Equity was $15.44B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.27.

Most Popular

Related Posts